Topical diphencyprone immunotherapy for cutaneous metastatic melanoma

The Australasian Journal of Dermatology
Diona L DamianJohn F Thompson

Abstract

Topical immunotherapy with contact sensitizers for metastatic melanoma was first reported more than 30 years ago. Diphencyprone (DPCP) immunotherapy is frequently used to treat cutaneous warts and alopecia areata, and we have previously reported the use of DPCP as a single agent to successfully treat extensive, radiotherapy-resistant melanoma metastases on the scalp. We now report DPCP treatment of a further six patients with cutaneous metastatic melanoma. Of seven patients treated with DPCP thus far, four have demonstrated complete responses of their cutaneous lesions and three have had partial responses. The treatment was well-tolerated by all patients. Topical immunotherapy with DPCP is inexpensive and relatively non-invasive and should be considered in patients with locally advanced skin metastases that are unsuitable for other therapies.

References

Jul 30, 1979·World Journal of Surgery·J E Goodnight, D L Morton
Apr 1, 1991·Annals of Plastic Surgery·P J Hurwitz
Jun 1, 1997·The Australasian Journal of Dermatology·R S Barnetson, G M Halliday
Sep 5, 2001·The British Journal of Dermatology·D A Buckley, A W Du Vivier
Aug 31, 2002·Cancer Immunology, Immunotherapy : CII·Christiane WackWolfgang H Fischer
Nov 18, 2003·The Australasian Journal of Dermatology·Jamie von Nida, Chris Quirk
Nov 16, 2005·Dermatology : International Journal for Clinical and Investigative Dermatology·Uwe Trefzer, Wolfram Sterry
Feb 6, 2007·Journal of the American Academy of Dermatology·Diona L Damian, John F Thompson
Oct 3, 2008·Melanoma Research·John F ThompsonEric Wachter

❮ Previous
Next ❯

Citations

Aug 3, 2013·Current Oncology Reports·Malcolm Hart Squires, Keith A Delman
Mar 13, 2013·American Journal of Clinical Dermatology·Elizabeth A Quigley, Allan C Halpern
Jul 28, 2012·BMC Complementary and Alternative Medicine·Marija DorđićZorica Juranić
Apr 23, 2013·Clinical & Developmental Immunology·Valerie R YanofskyJohn A Carucci
Aug 16, 2011·Journal of the American Academy of Dermatology·Diona L Damian, Robyn P M Saw
Jun 1, 2013·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Annette PflugfelderUNKNOWN German Society of Dermatology
Aug 23, 2011·Journal of Surgical Oncology·Alessandro TestoriJavier Soteldo
Jan 10, 2013·The British Journal of Surgery·C Allan, B M Smithers
Feb 14, 2014·Journal of Surgical Oncology·Diona L DamianJohn F Thompson
Nov 9, 2014·Expert Opinion on Pharmacotherapy·Sarah SlootJonathan S Zager
Jun 8, 2017·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Thomas K EigentlerClaus Garbe
Jul 3, 2019·Journal of the European Academy of Dermatology and Venereology : JEADV·A BullenK Khosrotehrani
Jul 12, 2019·The Journal of Dermatological Treatment·Yalda NahidiMona Najaf Najafi
Dec 7, 2013·Expert Review of Clinical Immunology·Ryan M TrowbridgeDevendra K Agrawal
Dec 7, 2019·Melanoma Management·Michael A Henderson
Feb 10, 2017·Case Reports in Medicine·Shelley J E HwangPablo Fernandez-Penas
May 4, 2018·Anais Brasileiros De Dermatologia·Ivana Lameiras GibbonsJoão Pedreira Duprat Neto
Feb 9, 2019·Journal of Surgical Oncology·Tavis ReadB Mark Smithers
Aug 16, 2019·Therapeutic Advances in Vaccines and Immunotherapy·Brendon J Coventry
Nov 7, 2019·Frontiers in Pharmacology·Claudia Robles-PlanellsClaudio Acuña-Castillo
Jan 13, 2017·Cancer Immunology, Immunotherapy : CII·Benjamin WeideGiuliano Elia
Mar 25, 2016·Cancer Control : Journal of the Moffitt Cancer Center·Sarah SlootJonathan S Zager
Jan 1, 2018·Anais Brasileiros De Dermatologia·IvanaLameiras GibbonsJoãoPedreira Duprat Neto
Nov 7, 2020·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Thuy Trang NguyenVan Giau Vo
Feb 11, 2011·Current Opinion in Oncology

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.